跳至主要内容
临床试验/NCT03836547
NCT03836547已完成不适用

Feasibility of a Multi Component Intervention in Patients With Severe Dyspnea and Obesity

Mayo Clinic3 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2019年12月19日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
28
试验地点
3
主要终点
Breathlessness

研究概览

简要总结

Researchers are trying to test the effectiveness and feasibility of a multicomponent lifestyle intervention to support weight loss decreases dyspnea in obese people with chronic lung disease and clinically significant breathlessness.

详细描述

Patient will be randomized to a 12-week intervention that uses the Weight watchers lifestyle program online, a Garmin Fitness Tracker, blue tooth scale and receive health coaching vs a wait-list control group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age ≥ 18 years.
  • •BMI >=35
  • •Dyspnea MRC class II or greater
  • •Diagnosis of lung disease
  • •Signed informed consent

排除标准

  • •Pregnancy
  • •Recent respiratory illness (within the last 6 weeks)
  • •Recent exacerbation of chronic lung disease (within the last 6 weeks)
  • •Already participating in a structured diet and/or exercise program
  • •Medical contraindication to weight loss (cancer)
  • •Medical contraindication to unsupervised exercise (unstable angina)

研究组 & 干预措施

Multicomponent Intervention for weight loss

Experimental

12-week intervention that consists of Weight Watcher on-line program, Garmin Fitness Tracker, blue-tooth scale, and telephonic health coaching.

干预措施: Coaching and Weight Loss for patients with dyspnea (Behavioral)

Wait-list Control

Active Comparator

The participant will receive usual care for 12 weeks and then will compassionately be offered the active intervention.

干预措施: Active Control (Behavioral)

结局指标

主要结局

Breathlessness

时间窗: baseline to 12 weeks

Chronic Respiratory Questionnaire Dyspnea

次要结局

  • Daily Steps(baseline to 12 weeks)
  • Disease specific quality of life(baseline to 12 weeks)
  • Percent Body Fat using InBody 770 Scale(baseline to 12 weeks)
  • Lean Body Mass (lbs.)using InBody 770 Scale(baseline to 12 weeks)
  • Weight using InBody 770 Scale(baseline to 12 weeks)
  • Skeletal Muscle Mass (lbs.) using InBody 770 Scale(baseline to 12 weeks)
  • Body Mass Index using InBody 770 Scale(baseline to 12 weeks)
  • Mindful Eating(baseline to 12 weeks)
  • Exercise Capacity(baseline to 12 weeks)
  • Sleep Efficiency(baseline to 12 weeks)
  • Sleep Time Measures(baseline to 12 weeks)
  • Daily Sedentary Time(baseline to 12 weeks)
  • Daily Physical Activity(baseline to 12 weeks)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Roberto P. Benzo

Principal Investigator

Mayo Clinic

研究点 (3)

Loading locations...

相似试验